While we included a similar number of patients with biopsy-proven MPO-ANCA-GN, approximatively followed for the same duration as compared to Ge et al. study, the discrepancy between the two cohorts may be explained by additional factors. This evidence concerns the gene MPO and ganglioneuroma.